A b s t r a c t
Solitary fibrous tumor (SFT) is a mesenchymal tumor characterized by ovoid cells, branching
, and mammary-type myofibroblastoma (4/4) , which were used as a control group, showed monoallelic or biallelic loss of RB1.
The absence of RB1 loss in SFTs suggests that they are not related to cellular angiofibroma, mammarytype myofibroblastoma, or spindle cell lipoma.
The entity now known as solitary fibrous tumor (SFT) was first described by Stout and Murray 1 in 1942 as a soft tissue tumor characterized by cells surrounding thick-walled, branching "staghorn" blood vessels. The lesional cells were thought to be derived from pericytes, and the term hemangiopericytoma was introduced. Although SFT was first recognized as a distinct pleural-based entity in 1931, it has subsequently been described in a variety of extrapleural sites. 2 As the morphologic overlap between SFT and hemangiopericytoma was acknowledged, there was a shift toward favoring the term solitary fibrous tumor to encompass these histologically similar entities. 3 Although the line of differentiation of SFT remains uncertain, there is some evidence to support fibroblastic/myofibroblastic origin. 4, 5 Regardless, it is accepted that the neoplastic cells are not derived from pericytes, and the term hemangiopericytoma is best thought of as a descriptive term rather than a diagnostic entity.
Recent work has shown that cellular angiofibroma harbors a monoallelic deletion of RB1, suggesting a genetic link between cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma. 6 While this group of tumors varies in clinical manifestations, all tumors share similar morphologic features and are characterized by bland ovoid to spindle-shaped cells with wispy collagen, variably sized thick-walled blood vessels, and immunoreactivity to CD34, similar to what is seen in classic SFT. Given the morphologic overlap of these entities, we tested a group of 40 SFTs and malignant SFTs to assess for loss of RB1 by fluorescence in situ hybridization (FISH).
Upon completion of this activity you will be able to:
• describe the clinicopathologic features of solitary fibrous tumor.
• compare and contrast the clinicopathologic features of cellular angiofibroma, mammary-type myofibroblastoma, and spindle cell lipoma.
• discuss the genetic link among cellular angiofibroma, mammary-type myofibroblastoma, and spindle cell lipoma.
The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit ™ per article. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity qualifies as an American Board of Pathology Maintenance of Certification Part II Self-Assessment Module.
The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.
Questions appear on p 1010. Exam is located at www.ascp.org/ajcpcme.
Materials and Methods

Case Selection
A total of 33 cases of SFT and 7 cases of malignant SFT with available formalin-fixed, paraffin-embedded tissue were selected from the Cleveland Clinic (Cleveland, OH) Anatomic Pathology database from January 1, 2000, to April 1, 2011. Cases classified as SFTs consisted of CD34+, ovoid-spindle-shaped cells admixed with variable amounts of hyalinized stroma and branching, staghorn-type blood vessels. While criteria for malignancy vary throughout the literature, we considered a tumor to be malignant if greater than 4 mitotic figures per 10 high-power fields (HPFs) were identified or the tumor exhibited significant nuclear pleomorphism, necrosis, or areas of increased cellularity. 3, 4, 7, 8 In addition, 1 case of cellular angiofibroma, 6 cases of spindle cell lipoma, and 4 cases of mammary-type myofibroblastoma with formalin-fixed, paraffin-embedded tissue were selected from the Cleveland Clinic Anatomic Pathology database. This group of tumors was characterized by bland, variably CD34+ cells. Spindle cell lipomas typically contained a lipomatous component and thick bundles of eosinophilic collagen and were located in the upper back, shoulder, and neck region. The diagnosis of cellular angiofibroma was considered if the tumor was located in the inguinal or vulvovaginal region and was highly vascular. Mammary-type myofibroblastomas arose at mammary and extramammary locations and expressed varying amounts of myogenic markers.
Tissue Microarrays
Two tissue microarrays (TMAs) containing the 40 SFTs and malignant SFTs were designed. A third TMA containing the cases of cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma was also created. For each case, the area with the most representative histologic features was selected from the tissue block. The cylindrical tissue samples (2 mm) were cored from the previously described areas in the blocks and extruded into the recipient array blocks using a manual tissue microarrayer (TMArrayer, Pathology Devices, Westminster, MD).
FISH Analysis
FISH studies for the detection of RB1 were carried out on interphase nuclei present on formalin-fixed, paraffinembedded tissue sections as reported previously. 9 A directly labeled SpectrumOrange DNA LSI (13q14; Rb locus; Vysis, Downers Grove, IL) probe was used for the assessment of chromosome 13 loss, while a directly labeled SpectrumGreen chromosome 8 enumeration DNA probe (CEP8; Vysis) was used as the control because an alphacentromeric chromosome 13 enumeration probe was not available. Only nuclei with at least 2 CEP8 signals were counted. A qualitative review was performed, with RB1 loss based on the loss of RB1 in at least 20% of the cells.
Results
We identified 33 cases of SFT and 7 cases of malignant SFT. Of the patients represented, 21 were men and 19 were women. The ages of patients ranged from 31 to 78 years (mean, 56.4 years). The tumors occurred in a variety of thoracic and extrathoracic locations. Histologic examination revealed variably cellular neoplasms composed of spindled to ovoid-shaped cells. In 25 of the 40 tumors, a prominent hemangiopericytoma-like vascular pattern could be identified at least focally ❚Image 1A❚, while the blood vessels were less conspicuous in the remaining tumors. Stromal hyalinization and thick bands of eosinophilic collagen were present in 29 of the lesions ❚Image 1B❚. Four tumors displayed lipomatous differentiation ❚Image 1C❚.
A subset of the SFTs in this study showed features that have been associated with aggressive behavior, including increased mitotic activity, increased cellularity, cytologic atypia, and necrosis ❚Image 2❚. 3, 4, 7, 10 Specifically, 5 of the tumors exhibited a focal increase in cellularity, and 4 tumors were diffusely hypercellular. Of the tumors, 6 showed mild cytologic atypia, 7 showed moderate cytologic atypia, and 4 showed severe nuclear atypia. In 7 tumors, there was necrosis ranging from 5% to 75% of the tumor (mean, 26%). The mitotic rate of the tumors ranged from 0 to 20 mitotic figures/10 HPFs (mean, 2.7 mitotic figures/10 HPFs). Based on these histologic features, 7 tumors were classified as malignant SFTs.
Immunohistochemical staining for CD34 was performed in 29 of the 40 cases. In 28 of 29 cases, CD34 was diffusely positive in the neoplastic cells ❚Image 1D❚. In the remaining case, CD34 staining was focal. A variety of other immunohistochemical stains were performed in a proportion of the cases, including cytokeratins, smooth muscle actin, desmin, S-100, HMB45, Melan A, CD31, and bcl-2. In the 2 cases in which it was applied, bcl-2 was positive; all the other markers were negative.
Follow-up was available for 38 of 40 patients, ranging from 0.5 to 132 months (average, 35.7 months). One patient had lymph node metastasis at diagnosis. In the remainder of patients, 26 had 12 or more months of follow-up. No recurrences or distant metastases were reported.
FISH analysis in 31 cases of SFT and 7 cases of malignant SFT failed to show loss of RB1 ❚Image 3A❚. Two cases of SFT had too few FISH signals and could not be evaluated. The case of cellular angiofibroma showed biallelic loss of RB1. Of the 6 cases of spindle cell lipoma, 5
showed monoallelic loss of RB1 ❚Image 3B❚, and the sixth case showed biallelic loss. Of the 4 cases of mammary-type myofibroblastoma, 3 showed monoallelic loss of RB1, and the fourth case showed biallelic loss. The clinicopathologic features of tumors are summarized in ❚Table 1❚.The results of the FISH studies are summarized in ❚Table 2❚.
Discussion
Spindle cell lipoma was first described by Enzinger and Harvey 11 in 1975 as a lipomatous tumor with a marked predilection for the shoulder and posterior neck region of middle-aged to elderly men. Although pleomorphic lipoma was initially thought to represent a separate entity, it is now accepted that both of these tumors are part of a spectrum of neoplasms characterized by similar clinical, morphologic, and genetic features. 12, 13 Morphologically, spindle cell/pleomorphic lipoma typically contains 3 components: mature adipose tissue; spindle cells arranged in short, parallel bundles; and ropy birefringent collagen ❚Image 4A❚. The proportions of these components may vary, and some tumors may have little or no fat. 3, 14 These tumors show strong staining for CD34. 15, 16 Myofibroblastoma was first described by Wargotz et al 17 though similar lesions had been reported earlier as "spindle cell tumor of the breast." 18, 19 More recently, these tumors have been noted at extramammary sites as well, and the term mammary-type myofibroblastoma is often used when referring to this group of tumors. 20 While earlier studies reported a male predominance, this tumor may also occur in female patients. 3, 17, 20 myofibroblasts admixed with broad bands of hyalinized collagen ❚Image 4B❚. 17 Hyalinized blood vessels can be found in some tumors but are not usually a prominent feature. Mature fat may also be found within these lesions. 17, 20 These tumors variably express CD34, desmin, and actin. 3, 17, 20 Cellular angiofibroma is a mesenchymal neoplasm that was initially described by Nucci et al 21 in 1997 and usually involves the vulvovaginal region of middle-aged women or inguinoscrotal region of adult men. 22 These tumors are typically well circumscribed with a multilobulated gross appearance. 22 Microscopically, cellular angiofibroma is composed of (RB1) by FISH, whereas all cases of cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma showed monoallelic or biallelic loss, arguing against the concept that SFT is genetically related to these entities.
We failed to show a genetic link between SFT and cellular angiofibroma, spindle cell lipoma, and mammarytype myofibroblastoma by assessing a series of SFTs and malignant SFTs for loss of RB1. Our findings suggest that although SFTs may share overlapping morphologic and immunophenotypic characteristics with cellular angiofibroma, mammary-type myofibroblastoma, and spindle cell lipoma, they are genetically unrelated.
short spindle cells in an edematous or fibrous stroma admixed with small to medium-sized, thick-walled, and often hyalinized blood vessels ❚Image 4C❚. 21, 22 Short bundles of collagen are often identified, and a subset of tumors contain mature adipose tissue as individual adipocytes or larger lobules of fat. 22 These tumors may express CD34 ❚Image 4D❚ with variable amounts of smooth muscle actin and desmin. 3, 6, 21, 22 In 1994, Mandahl and colleagues 13 studied a group of spindle cell and pleomorphic lipomas and showed an association with monosomy 16 or loss of 16q. Most of the tumors also showed monosomy 13 or partial loss of 13q. Dal Cin and coworkers 23 subsequently showed that aberrations of chromosome 13 may occur independently from deletion of 16q. The morphologic link between mammary-type myofibroblastoma and spindle cell lipoma was acknowledged early on by Chan et al 18 and Toker et al. 19 The genetic relationship of these 2 entities was confirmed by Pauwels et al 24 in 2000 when they described 2 cases of myofibroblastoma, both of which showed partial monosomy 13q. Subsequently, Maggiani et al 25 showed losses of RB/13q14 and FKHR/13q14 loci within an extramammary-type myofibroblastoma, providing further evidence of the link between myofibroblastoma and spindle cell lipoma. Cellular angiofibroma also shares morphologic features of spindle cell lipoma and mammary-type myofibroblastoma, and recent work has suggested that all 3 entities may be related. In 2007, Hameed and colleagues 26 described loss of chromosomes 13 and 16 in a case of cellular angiofibroma. Additional FISH studies of the same case revealed deletion of 13q14 (RB1). Maggiani et al 25 described 2 additional cases of cellular angiofibroma in which FISH studies showed deletion of the chromosome 13q14 region that spanned RB1 and FOX1A1 loci. In 2011, Flucke and colleagues 6 showed monoallelic deletion of RB1 by FISH in a series of 7 cases of cellular angiofibroma.
SFT is a mesenchymal neoplasm that shares many morphologic features with spindle cell lipoma, mammary-type myofibroblastoma, and cellular angiofibroma, including uniform fusiform to spindled cells, variable stromal hyalinization and mature adipose tissue, a distinct vasculature, and CD34 immunoreactivity. Given the morphologic and immunophenotypic overlap, it has been suggested that SFT may belong to this group of lesions. 27, 28 Although Miettinen and colleagues 29 found that cytogenetic abnormalities were more common in SFTs larger than 10 cm, few recurrent numeric or structural aberrations have been reported. In a study of 12 pleural-based SFTs, Krismann and coworkers 42 showed that 4 cases showed losses on arm 13q by comparative genomic hybridization. Other studies have also described loss in chromosome 13 in rare cases of SFT. 29, 41, 46 In our group of 38 cases of SFT and malignant SFT with evaluable FISH signals, none (0/38) showed loss of 13q14
